首頁 > 市場調查報告書 > 製藥

眼科藥物

市場調查報告書

商品編碼

1417404

全球乾性老齡化相關黃斑部病變市場：趨勢、預測與競爭分析（-2030）

Dry Age Related Macular Degeneration Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2024年01月29日 | 出版商:

Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2024年至2030年，全球乾性老齡化黃斑部病變市場規模將以7.1%的年複合成長率成長。該市場的主要促進因素是老年人口的增加和老齡化黃斑部病變盛行率的增加。全球乾性老齡化黃斑部病變市場前景廣闊，在醫院和診所、診斷中心以及學術和研究機構市場中蘊藏著未來性。

乾性老齡化黃斑部病變市場洞察

Lucintel預測，由於老年人口的增加，75歲及以上的人口在預測期內將經歷最大的成長。

在這個市場中，由於醫院安裝了先進和全面的治療設施，醫院和診所將繼續成為最大的細分市場。

由於政府舉措和財政支持進一步推動該地區的市場擴張，預計北美地區將在預測期內實現最高成長。

常問問題

Q1.市場成長預測如何？

A1. 預計 2024 年至 2030 年，全球乾性老齡化黃斑部病變市場將以 7.1% 的年複合成長率成長。

Q2.影響市場成長的主要促進因素有哪些？

A2. 此市場的主要促進因素是老年人口的增加和老齡化黃斑部病變盛行率的增加。

Q3.市場的主要細分市場有哪些？

A3. 乾性老齡化黃斑部病變市場在醫院/診所、診斷中心、學術/研究機構市場的未來性廣闊。

Q4.市場上主要企業有哪些？

A4.乾性老齡化黃斑部病變的主要企業如下。

Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research

Q5.未來最大的細分市場是什麼？

A5.Lucintel預測，由於老年人口的增加，75歲及以上的人口在預測期內將經歷最大的成長。

Q6. 未來五年預計哪個地區將成為最大的市場？

A6. 由於政府舉措和財政支持進一步促進該地區的市場擴張，預計北美地區將在預測期內呈現最高成長。

Q7. 可以客製化報告嗎？

A7. 是的，Lucintel 提供 10% 的客製化服務，無需額外費用。

宏觀經濟趨勢（2018-2023）與預測（2024-2030）
全球乾性老齡化黃斑部病變市場趨勢（2018-2023）與預測（2024-2030）
全球乾性老齡化黃斑部病變市場：依年齡層別
- 75歲以上
- 60歲以上
- 40歲以上
全球乾性老齡化黃斑部病變市場：依診斷及治療分類
- 治療
- 診斷
全球乾性老齡化黃斑部病變市場：依給藥途徑
- 口服
- 注射
全球乾性老齡化黃斑部病變市場：依最終用途產業
- 醫院/診所
- 診斷中心
- 學術研究所
- 其他

第4章市場趨勢與預測分析：按地區（2018-2030）

全球乾性老齡化黃斑部病變市場：按地區
北美洲
歐洲
亞太地區
其他地區

第5章競爭分析

產品系列分析
營運整合
波特五力分析

第6章成長機會與策略分析

成長機會分析
- 按年齡層別
- 透過診斷/治療
- 依給藥途徑
- 按最終用途行業
- 按地區
全球乾性老齡化黃斑部病變市場的新興趨勢
戰略分析
- 新產品開發
- 擴大全球乾性老齡化黃斑部病變市場的產能
- 全球乾性老齡化黃斑部病變市場的合併、收購及合資企業
- 認證和許可

第7章主要企業概況

Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research

簡介目錄

Dry Age Related Macular Degeneration Trends and Forecast

The future of the global dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets. The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.

A more than 150-page report is developed to help in your business decisions.

Dry Age Related Macular Degeneration by Segment

The study includes a forecast for the global dry age related macular degeneration by age group, diagnosis & treatment, route of administration, end use industry, and region.

Dry Age Related Macular Degeneration Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

Above 75 Years
Above 60 Years
Above 40 Years

Dry Age Related Macular Degeneration Market by Diagnosis & Treatment [Shipment Analysis by Value from 2018 to 2030]:

Treatment
Diagnosis

Dry Age Related Macular Degeneration Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

Oral
Injectables

Dry Age Related Macular Degeneration Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

Hospitals & Clinics
Diagnostic Centers
Academic & Research Institutes
Others

Dry Age Related Macular Degeneration Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Dry Age Related Macular Degeneration Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dry age related macular degeneration companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dry age related macular degeneration companies profiled in this report include-

Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research

Dry Age Related Macular Degeneration Market Insights

Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.

Within this market, hospitals & clinics will remain the largest segment due to the installation of advanced and comprehensive treatment facilities in hospitals.

North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.

Features of the Global Dry Age Related Macular Degeneration Market

Market Size Estimates: Dry age related macular degeneration market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dry age related macular degeneration market size by various segments, such as by age group, diagnosis & treatment, route of administration, end use industry, and region in terms of value ($B).

Regional Analysis: Dry age related macular degeneration market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different age group, diagnosis & treatment, route of administration, end use industry, and regions for the dry age related macular degeneration market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dry age related macular degeneration market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for dry age related macular degeneration market?

Answer: The global dry age related macular degeneration market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the dry age related macular degeneration market?

Answer: The major drivers for this market are rising elderly populations and growing incidence of age-related macular degeneration.

Q3. What are the major segments for dry age related macular degeneration market?

Answer: The future of the dry age related macular degeneration market looks promising with opportunities in the hospitals & clinics, diagnostic centers, and academic & research institutes markets.

Q4. Who are the key dry age related macular degeneration market companies?

Answer: Some of the key dry age related macular degeneration companies are as follows.

Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research

Q5. Which dry age related macular degeneration market segment will be the largest in future?

Answer: Lucintel forecasts that above 75 years is expected to witness largest growth over the forecast period due to rising population of senior patients.

Q6. In dry age related macular degeneration market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to government initiatives and financial support are further driving the expansion of this market in this region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the dry age related macular degeneration market by age group (above 75 years, above 60 years, and above 40 years), diagnosis & treatment (treatment and diagnosis), route of administration (oral and injectables), end use industry (hospitals & clinics, diagnostic centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Dry Age Related Macular Degeneration Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Dry Age Related Macular Degeneration Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Dry Age Related Macular Degeneration Market by Age Group
- 3.3.1: Above 75 Years
- 3.3.2: Above 60 Years
- 3.3.3: Above 40 Years
3.4: Global Dry Age Related Macular Degeneration Market by Diagnosis & Treatment
- 3.4.1: Treatment
- 3.4.2: Diagnosis
3.5: Global Dry Age Related Macular Degeneration Market by Route of Administration
- 3.5.1: Oral
- 3.5.2: Injectables
3.6: Global Dry Age Related Macular Degeneration Market by End Use Industry
- 3.6.1: Hospitals & Clinics
- 3.6.2: Diagnostic Centers
- 3.6.3: Academic & Research Institutes
- 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Dry Age Related Macular Degeneration Market by Region
4.2: North American Dry Age Related Macular Degeneration Market
- 4.2.2: North American Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.3: European Dry Age Related Macular Degeneration Market
- 4.3.1: European Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
- 4.3.2: European Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.4: APAC Dry Age Related Macular Degeneration Market
- 4.4.1: APAC Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
- 4.4.2: APAC Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.5: ROW Dry Age Related Macular Degeneration Market
- 4.5.1: ROW Dry Age Related Macular Degeneration Market by Age Group: Above 75 Years, Above 60 Years, and Above 40 Years
- 4.5.2: ROW Dry Age Related Macular Degeneration Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Age Group
- 6.1.2: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Diagnosis & Treatment
- 6.1.3: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Route of Administration
- 6.1.4: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by End Use Industry
- 6.1.5: Growth Opportunities for the Global Dry Age Related Macular Degeneration Market by Region
6.2: Emerging Trends in the Global Dry Age Related Macular Degeneration Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Dry Age Related Macular Degeneration Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dry Age Related Macular Degeneration Market
- 6.3.4: Certification and Licensing